Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:38 PM
Ignite Modification Date:
2025-12-24 @ 10:38 PM
NCT ID:
NCT01400035
Eligibility Criteria:
Inclusion Criteria:
* Male or female, age 40-80
* The onset of the infarction between 48 hours and 1 month
* CT / MRI results show cerebral infarction with deficit of neurological function.
* CT or MRI confirms no intracranial hemorrhage
* NIHSS score ≥ 3
* The subject agree to sign the informed consent form
Exclusion Criteria:
* Evidence of acute or chronic intracranial hemorrhage, subarachnoid hemorrhage, intracranial arteriovenous malformation, aneurysm or neoplasm based on CT / MRI examination
* NIHSS score ≥ 17
* Coma patient
* Existed disorders or conditions that would interfere neurological assessments (eg. dementia, psychiatric disorder, etc.)
* Intracranial tumor, arteriovenous malformation, aneurysm, or intracranial surgery
* Active peptic ulcer disease
* Complicated with severe hepatic and renal disorder (ALT, AST 3.0 times higher than normal value; BUN or Cr more than 1.5 times the normal value) and severe disorder in hematopoietic system and endocrine system.
* Bleeding tendency or blood disease
* Plan to perform operation and carotid angioplasty
* With severe congestive heart failure or acute myocardial infarction
* Participate in other clinical trials at the same time, or withdrawal within 3 months
* Allergic or contraindicated to vinpocetine or other treatment medication
* Investigator think the subject is not suitable to participate in this trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT01400035
Study Brief:
Protocol Section:
NCT01400035